References
- Beck-Sauge CM, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States. 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167: 1247–51.
- Nguyen HM, Peacock JE, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617–23.
- Gumbo T, Isada CM, Hall G, Karafa MT, Gordon SM. Candida glabrata fungemia. Clinical features of 139 patients. Medicine (Baltimore) 1999; 78: 220–7.
- Gumbo T, Isada CM, Muschler GF, Longworth DL. Candida (Torulopsis) glabrata septic arthritis. Clin Infect Dis 1999; 29: 208–9.
- Nayeri F, Cameron R, Chryssanthou E, Johannson L, Soderstrom C. Candida glabrata prosthesis infection following pyelonephritis and septicemia. Scand J Infect Dis 1997; 29: 635–8.
- Dwyer K, McDonald M, Fitzpatrick T. Presentation of Candida glabrata spinal osteomyelitis 25 months after documented candidemia. Aust N Z J Med 1999; 29: 571–2.
- Clancy CJ, Barchiesi L, Flaconi DiFranscesco L, Morris AJ, Snydman DR, Yu VL, et al. Clinical manifestations and molecular epidemiology of late recurrent candidemia, and implications for management. Eur J Microbiol Infect Dis 2000; 19: 585–92.
- Curran MP, Lenke LG. Torulopsis glabrata spinal osteomyelitis involving two contiguous vertebrae. A case report. Spine 1996; 21: 866–70.
- Owen PG, Willis BK, Benzel EC. Torulopsis glabrata vertebral osteomyelitis. J Spinal Disord 1992; 5: 370–3.
- Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.